Fløtten, Ø., Grønberg, B. H., Bremnes, R., Amundsen, T., Sundstrøm, S., Rolke, H., . . . von Plessen, C. (2012). Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. Nature Publishing Group.
Style de citation ChicagoFløtten, Ø, et al. Vinorelbine and Gemcitabine Vs Vinorelbine and Carboplatin As First-line Treatment of Advanced NSCLC. A Phase III Randomised Controlled Trial By the Norwegian Lung Cancer Study Group. Nature Publishing Group, 2012.
Style de citation MLAFløtten, Ø, et al. Vinorelbine and Gemcitabine Vs Vinorelbine and Carboplatin As First-line Treatment of Advanced NSCLC. A Phase III Randomised Controlled Trial By the Norwegian Lung Cancer Study Group. Nature Publishing Group, 2012.